Hemofarm’s prescription drugs, called Rx drugs, are the most common products in the pharmaceutical market of Serbia
Hemofarm's prescription drugs, known as Rx, are the most represented products in the pharmaceutical market of Serbia.
The portfolio includes 13 out of a total of 14 pharmacotherapeutic groups, covering a wide range of diagnostic indications.
Hemofarm's leading Rx products in Serbia (by INN) are:
- OCRELIZUMAB
- BROMAZEPAM
- RIVAROXABAN
- LORAZEPAM
- METFORMIN
- DICLOFENAC
- AMOXICILLIN, CLAVULANIC ACID
- SODIUM CHLORIDE
- ACETYLSALICYLIC ACID
- AZITHROMYCIN